Hematopoietic stem cell transplantation for de novo erythroleukemia: A study of the European Group for Blood and Marrow Transplantation (EBMT)

Blood

Volumn 100, Issue 9, 2002, Pages 3135-3140

  Fouillard, Loïc ^a,b   Labopin, Myriam ^a   Gorin, Norbert Claude ^b   Polge, Emmanuelle ^c   Prentice, Hugh Grant ^d   Meloni, Giovanna ^e   Reiffers, Josy ^f   Pigneux, Arnaud ^g   Willemze, Roel ^h   Schattenberg, Anton ⁱ   Sica, Simona ^j   Lagrange, Monique ^a   Fenneteau, Odile ^a   Perot, Christine ^b   Frassoni, Francesco ^b  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; ERYTHROLEUKEMIA; EUROPE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGISTER; SIBLING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036839015     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V100.9.3135     Document Type: Article

References (42)

1. Copelli M, Di una emopatia sistemizzata rapresentata da una imperplasia eritroblastica (eritronatosis). Pathologica. 1912;4:460.
2. Di Guglielmo G, Richerche di ematologia, I: Un caso dierytro-leucemia. Folia Med. 1917;3:386.
3. Moeschlin S, Erythroblastosen, erythroleukamien und erythroblastamien. Folia Haematol (Leipz). 1940;64:262.
4. Dameshek W, The Di Guglielmo's syndrome. Blood. 1958;13:192.
5. Dameshek W, Gunz F. Leukemia. New York, NY: Grune & Stratton; 1964.
6. Bennet JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. Br J Haematol. 1976;33:451.
7. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 1985;103:626-629.
8. Roggli VL, Saleem A. Erythroleukemia: A study of 15 cases and literature review. Cancer. 1982;49: 101-108.
9. Atkinson H, Hrisinko MA, Weil SC. Erythroleukemia: A review of 15 cases meeting 1985 FAB criteria and survey of the literature. Blood Rev. 1993;6:204-214.
10. Schwartz AD, Zelson JH, Pearson HA. Acute myelogenous leukemia with compensatory but ineffective erythropoiesis: DiGuglielmo's syndrome. J Pediatr. 1970;77:653-657.
11. Bloomfield CD, Brunning RD, Kennedy BJ, Daunorubicin-prednisone treatment of erythropoiesis. Ann Intern Med. 1974;81:746-750.
12. Hetzel P, Gee TS. A new observation in the clinical spectrums of erythroleukemia: A report of 46 cases. Am J Med. 1978;64:765-772.
13. Roggli VL, Subach J, Saleem A. Prognostic factors and treatment effects on survival in erythroleukemia: A retrospective study of 134 cases. Cancer. 1981;48:1101-1105.
14. Frydecka I, Brodzka W, Lawinska B, Sciborski R. Clinical course and results of treatment of erythroleukemia. Folia Haematol. 1984;111:283-289.
15. Olopade OL, Thangavelu M, Larson RA, et al. Clinical, morphological and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 1992;80:2873-2882.
16. Burnett AK, Goldstone AH, Stevens RMF, et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial. Lancet. 1998;351:700-708.
17. Slovack ML, Kopecky LJ, Cassileth PA, et al. Karyotype analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075-4083.
18. Reiffers J, Stoppa AM, Attal M, et al. Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: The BGMT 87 study. Leukemia. 1996;10:1874-1882.
19. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med. 1995;332: 217-223.
20. Gorin NC. Autologous stem cell transplantation in acute myelocytic leukemia: A review. Blood. 1998;92:1073-1090.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1957;53:457-481.
22. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
23. Sierra J, Brunet S, Granena A, et al. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. J Clin Oncol. 1996;14:1353-1363.
24. Harrousseau JL, Cahn JY, Pignon B, et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. Blood. 1997;90:2978-2986.
25. Kogawa K, Sekine I, Masuda T, et al. Bone marrow transplantation for erythroleukemia: A case report. Acta Paediatr Jpn. 1994;36:693-696.
26. Killick S, Matutes E, Powles RL, et al. Acute erythroid leukemia (M6): Outcome of bone marrow transplantation. Leuk Lymphoma. 1999;35:99-107.
27. Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med. 1998;339:1649-1656.
28. Löwenberg B, Verdonck LJ, Dekker AW, et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: Results of a Dutch prospective study. J Clin Oncol. 1990;8: 287-294.
29. De Witte T, van Biezen A, Hermans J, et al. Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Blood. 1997;90: 3853-3857.
30. Cuneo A, Orshoven AV, Michaux JL, et al. Morphological, immunological and cytogenetic studies in erythroleukemia: Evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Br J Haematol. 1990;75:346-354.
31. Anderson JE, Appelbaum FR, Fisher LD, et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood. 1993;82:677-681.
32. Anderson JE, Appelbaum FR, Storb R. An update on allogeneic marrow transplantation for myelodysplastic syndrome. Leuk Lymphoma. 1995;17: 95-99.
33. Ratanaatharathorn V, Karanes C, Uberti J, et al. Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood. 1993;81:2194-2199.
34. Nevill TJ, Shepherd JD, Reece DE, et al. Treatment of myelodysplastic syndrome with busulfancyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant. 1992;10: 445-450.
35. Sutton L, Leblond V, Le Maignan C, et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: Outcome of 86 patients. Bone Marrow Transplant. 1991;7:39.
36. De Witte T, Zwaan F, Hermans J, et al. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: A survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol. 1990;74:151-155.
37. Longmore G, Guinan E, Weinstein JH, et al. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphoblastic leukemia. J Clin Oncol. 1990;8:1707-1714.
38. O'Donnel MR, Nademanee AP, Snyder DS, et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndrome. J Clin Oncol. 1987;5:1822-1826.
39. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649-1660.
40. Reiffers J, Labopin M, Sanz M, et al. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: An EBMT study. Bone Marrow Transplant. 2000;25: 1115-1119.
41. Kadamn PR, Balsara BR, Zafaraullah KZ, Dadabhoy KD, Bhisey AN, Advani SSH. Cytogenetic features of erythroleukemia (EL): A study of 11 cases. Cancer Genet Cytogenet. 1990;50:89-96.
42. Helm S, Miltelman F. Acute myeloid leukemia. In: Cancer Cytogenetics. 2nd Ed. New York, NY: Wiley-Liss; 1995:69-140.